Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 43

Trial Status

Other3

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT00702793Phase 4Withdrawn
Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
PsychosisSchizoaffectiveSchizophrenia
Studydirector
NCT02213887Phase 4Withdrawn
Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
Gastroesophageal RefluxPsychotic Disorders
Studydirector
NCT02286206Phase 4Withdrawn
Study of the Effect of Dosing on Clozapine Levels
Psychotic DisordersSchizophrenia
Studydirector

Research Network

Collaboration Network

11 collaborators·22 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of British Columbia

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

William Honer, MD

University of British Columbia

Similar
7 trials

Shared therapeutic areas:

Psychotic DisordersSchizophreniaGastroesophageal Reflux+1 more

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 3 trials
Similarity Score52%

Ric M. Procyshyn, Ph.D

University of British Columbia

Similar
3 trials

Shared therapeutic areas:

Psychotic DisordersSchizophreniaGastroesophageal Reflux+1 more

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 3 trials
Similarity Score52%

Randall White, MD

University of British Columbia

Moderately Similar
2 trials

Shared therapeutic areas:

Psychotic DisordersGastroesophageal RefluxSchizophrenia

Worked with same sponsors:

University of British Columbia
Collaborated on 2 trials
Similarity Score38%

Sean Flynn, MD

University of British Columbia

Moderately Similar
1 trials

Shared therapeutic areas:

Psychotic DisordersSchizoaffectiveSchizophrenia

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 1 trial
Similarity Score34%

Chris Schenk, MD

Riverview Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Psychotic DisordersSchizoaffectiveSchizophrenia

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 1 trial
Similarity Score34%

Joyce Coutts, MD

Forensic Psychiatric Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Psychotic DisordersSchizoaffectiveSchizophrenia

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 1 trial
Similarity Score34%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
20 trials

Shared therapeutic areas:

SchizophreniaPsychotic Disorders
Similarity Score15%

Sanjeev Pathak, MD

Alkermes, Inc.

Related
13 trials

Shared therapeutic areas:

Schizophrenia
Similarity Score8%

Paula Fernstrom

Nexium Global Product Director, AstraZeneca

Related
18 trials

Shared therapeutic areas:

Gastroesophageal Reflux
Similarity Score8%

Ganesh Raghu, MD

University of Washington

Related
5 trials

Shared therapeutic areas:

Gastroesophageal Reflux
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00702793Phase 4StudyDirector

Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)

PsychosisSchizoaffectiveSchizophrenia
Withdrawn
NCT02213887Phase 4StudyDirector

Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications

Gastroesophageal RefluxPsychotic Disorders
Withdrawn
NCT02286206Phase 4StudyDirector

Study of the Effect of Dosing on Clozapine Levels

Psychotic DisordersSchizophrenia
Withdrawn

All 3 trials loaded